Henrik Bjursten

Cardiac surgeon
Clinical Sciences - Lund, Sweden

Latest contributions

PCR Innovators Day - Competition for the Jon DeHaan Award

19 May 2022 – From EuroPCR 2022

Best-graded contributions for the Innovators Day were considered for this competition. Among them, find out more about transcatheter calcium modifying treatment of the stenotic aortic valve, capture technology for treating mitral regurgitation, or transcatheter microwave renal denervation guided by aorticorenal ganglion pacing.

PCR Innovators Day - Competition for the Jon DeHaan Award

EuroPCR 2021 Hotlines / Late-Breaking Trials: SWENTRY, Redo-TAVI, Early neo2, PORTICO NG, and Evolut Low Risk Trial

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in TAVI:

  • SWENTRY registry, Swedish Stroke Registry and National Patient Registry: late stroke after TAVI
  • Redo-TAVI registry: implantation of a supplementary transcatheter aortic valve during TAVI
  • Acurate neo2 TAVI valve results from the Early neo2 registry
  • PORTICO NG: 30-day outcomes from a...
EuroPCR 2021 Hotlines / Late-Breaking Trials: SWENTRY, Redo-TAVI, Early neo2, PORTICO NG, and Evolut Low Risk Trial

EuroPCR 2021 Hotlines / Late-Breaking Trials: STS-ACC TVT Registry, AMTRAC, MATCH-BALL, SWENTRY, and ITAL-neo Registry

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in TAVI:

  • STS/ACC TVT Registry: TAVR for bicuspid aortic valve stenosis in low surgical risk population
  • AMTRAC Valve Registry: regression of mitral regurgitation and outcomes following TAVR
  • MATCH-BALL study: matched comparison of outcomes with Balloon-Expandable transcatheter heart valve
  • SWENTRY registry: radiological predictors...
EuroPCR 2021 Hotlines / Late-Breaking Trials: STS-ACC TVT Registry, AMTRAC, MATCH-BALL, SWENTRY, and ITAL-neo Registry

Trials and registries - Long term clinical outcomes after TAVI

21 May 2019 – From EuroPCR 2019

Consult this session to learn about the latest trials and registries regarding the long term clinical outcomes after TAVI, such as CHOICE, INTeNSE, RASTAVI, and more!